Fig. 2From: Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains frameworkSummary by year indicating percentage of participants that correctly specified antenatal magnesium sulphate guideline recommendations (regarding: dose, timing, gestational age, and reasons for preterm birth)Back to article page